Archives: Featured Coverage

Click Below to Sort Topics

Amicus Wins Top Prize at UK Prix Galien Awards

Amicus Wins Top Prize at UK Prix Galien Awards

Amicus Therapeutics wins the UK Prix Galien award for Innovative Product, marking the first time in the history of the awards that an orphan drug received this esteemed recognition.

Amicus CEO on a Mission to Cure Pompe and Help His Two Children

Amicus CEO on a Mission to Cure Pompe and Help His Two Children

John Crowley, Chairman and CEO of Amicus Therapeutics, was interviewed by Pompe Disease News sharing his personal experience with Pompe disease, Enzyme Replacement Therapy (ERT), and the optimistic future for the next-generation of ERT and gene therapy.

Amicus Chairman & CEO John F. Crowley Featured on Entrepreneur Weekly Podcast

Amicus Chairman & CEO John F. Crowley Featured on Entrepreneur Weekly Podcast

Amicus Chairman and CEO John Crowley sits down with Entrepreneur Weekly’s Alan Taylor to discuss his personal story with Pompe disease and how he is spearheading an entrepreneurial culture within the biotech industry.

Amicus-UPenn Partnership Named ‘Deal Of The Year’ By Penn Center For Innovation

Amicus-UPenn Partnership Named ‘Deal Of The Year’ By Penn Center For Innovation

Amicus Therapeutics and Dr. James Wilson with the UPenn Gene Therapy Program are awarded Deal of the Year for their collaboration to advance AAV gene therapy research for rare metabolic disorders.

Amicus Expands to Emerging Philadelphia Gene Therapy Hub

Amicus Expands to Emerging Philadelphia Gene Therapy Hub

Amicus Therapeutics featured across media outlets for establishing their presence in Philadelphia’s uCity Square.

Media Coverage Includes:

Jayne Gershkowitz Featured on PharmaVOICE Woman of the Week (WoW) Podcast

Jayne Gershkowitz Featured on PharmaVOICE Woman of the Week (WoW) Podcast

Jayne Gershkowitz, Chief Patient Advocate at Amicus Therapeutics, is a passionate advocate and expert in a wide variety of issues affecting individuals with rare diseases and their families. She has more than 18 years of experience of strategic marketing, resource development and executive management in nonprofit healthcare and the rare disease patient community.

In the podcast she shares her experiences and perspectives on the impact of patient advocacy for patients and families living with rare diseases.

Amicus Co-Sponsor of Global Genes “RARE Webinar – Precision Medicine”

Amicus Co-Sponsor of Global Genes “RARE Webinar – Precision Medicine”

For the full webinar Listen Here.

PP-GA-ALL-0004-8019

Globes Profiles John C. Crowley,  Chairman and CEO

Globes Profiles John C. Crowley, Chairman and CEO

Globes, the leading financial newspaper in Israel, profiles John Crowley’s personal story and Amicus Therapeutics